|
Reducing Urban Cervical Cancer Disparities
RECRUITINGN/ASponsored by Fox Chase Cancer Center
Actively Recruiting
PhaseN/A
SponsorFox Chase Cancer Center
Started2024-08-28
Est. completion2027-04
Eligibility
Age18 Years – 90 Years
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT06416150
Summary
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Eligibility
Age: 18 Years – 90 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites), * referral for colposcopic evaluation at the clinic sites, * able to communicate with ease in English, * have a cell phone with texting ability, and * competent to give consent. Exclusion Criteria: * are pregnant at the time of recruitment, * display current evidence or have a history of positive invasive carcinoma of the cervix, or * require follow-up but not a colposcopy.
Conditions3
CancerCervical CancerPapilloma Viral Infection
Locations3 sites
New Jersey
1 siteRutgers, The State University of New Jersey
New Brunswick, New Jersey, 08901
Pennsylvania
2 sitesThomas Jefferson University
Philadelphia, Pennsylvania, 19107
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorFox Chase Cancer Center
Started2024-08-28
Est. completion2027-04
Eligibility
Age18 Years – 90 Years
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT06416150